Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 5 hours ago

Google shows it’s not out of the AI race just yet

The company’s Gemini 4 Argon announcement shows Google is back with the pack when it comes to cutting-edge AI models.

MarketWatch

marketsabout 7 hours ago

The 15 worst-performing S&P 500 stocks during a dismal September

The S&P 500 has gained slightly in September, but three-quarters of its components have declined.

MarketWatch

marketsabout 7 hours ago

How the ‘AI put’ has become the only thing that matters for stocks

While investors worry a spike in global bond yields will trigger a selloff in U.S. equities, strategists at BofA Global Research say the real threat lies elsewhere.

MarketWatch